Increasing Patient Involvement in Drug Development.

Area of Science:

• Health Services Research
• Pharmaceutical Sciences
• Patient Engagement

Background:

• Healthcare systems increasingly prioritize patient needs and preferences for value-based treatments.
• While patient engagement in research is growing, the pharmaceutical industry lags in integrating patient input into drug development.
• Aligning drug development with patient needs is crucial for maximizing value and minimizing costs.

Purpose of the Study:

• To assess the current level of patient involvement in the pharmaceutical drug development process.
• To identify opportunities and challenges associated with patient engagement in drug development.

Main Methods:

• Conducted semistructured interviews with pharmaceutical industry leaders, patients, a research funder, a regulator, a patient advocacy group, and a caregiver.
• Utilized qualitative data to explore patient involvement in drug development.

Main Results:

• Few large-scale examples of patient involvement in drug development were reported, despite acknowledgment of its benefits.
• Identified barriers include adverse event reporting burdens, concerns about patient representativeness, and cost-benefit analyses.
• Challenges in patient recruitment and ensuring meaningful participation were also noted.

Conclusions:

• The pharmaceutical industry must innovate to demonstrate product value based on patient outcomes.
• Recognizing and integrating patient value across the product lifecycle is essential.
• Transforming organizational perceptions and practices is necessary to enhance patient involvement in drug development.